{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:47:35Z","timestamp":1786996055381,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["21KJD310002"],"award-info":[{"award-number":["21KJD310002"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.prp.2023.154602","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T23:09:47Z","timestamp":1686179387000},"page":"154602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["SOX9\/NFIA promotes human ovarian cancer metastasis through the Wnt\/\u03b2-catenin signaling pathway"],"prefix":"10.1016","volume":"248","author":[{"given":"Rong","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4943-1859","authenticated-orcid":false,"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2023.154602_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7314\/APJCP.2014.15.1.191","article-title":"Time trends of ovarian cancer incidence in China","volume":"15","author":"Wang","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.prp.2023.154602_bib2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3802\/jgo.2014.25.3.174","article-title":"Trends in gynecologic cancer mortality in East Asian regions","volume":"25","author":"Lee","year":"2014","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.prp.2023.154602_bib3","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2023.154602_bib4","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chin. Med J."},{"key":"10.1016\/j.prp.2023.154602_bib5","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian cancer","volume":"2","author":"Matulonis","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"Suppl 1","key":"10.1016\/j.prp.2023.154602_bib6","doi-asserted-by":"crossref","first-page":"i58","DOI":"10.1093\/annonc\/mdw088","article-title":"Optimal primary therapy of ovarian cancer","volume":"27","author":"Bookman","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2023.154602_bib7","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1038\/s41467-020-17030-w","article-title":"miR-181a initiates and perpetuates oncogenic transformation through the regulation of innate immune signaling","volume":"11","author":"Knarr","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2023.154602_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6754040","article-title":"SOX9 stem-cell factor: clinical and functional relevance in cancer","volume":"2019","author":"Aguilar-Medina","year":"2019","journal-title":"J. Oncol."},{"key":"10.1016\/j.prp.2023.154602_bib9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.devcel.2019.04.010","article-title":"Epithelial-mesenchymal plasticity in cancer progression and metastasis","volume":"49","author":"Lu","year":"2019","journal-title":"Dev. Cell"},{"key":"10.1016\/j.prp.2023.154602_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc3447","article-title":"Regulatory networks defining EMT during cancer initiation and progression","volume":"13","author":"De Craene","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2023.154602_bib11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","article-title":"EMT transition states during tumor progression and metastasis","volume":"29","author":"Pastushenko","year":"2019","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.prp.2023.154602_bib12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10555-016-9648-7","article-title":"EMT, cell plasticity and metastasis","volume":"35","author":"Chaffer","year":"2016","journal-title":"Cancer Metastas. Rev."},{"key":"10.1016\/j.prp.2023.154602_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12967-019-1895-2","article-title":"SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt\/beta-catenin pathway","volume":"17","author":"Huang","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.prp.2023.154602_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8267021","article-title":"Expression and clinical relevance of SOX9 in gastric cancer","volume":"2019","author":"Mesquita","year":"2019","journal-title":"Dis. Markers"},{"key":"10.1016\/j.prp.2023.154602_bib15","doi-asserted-by":"crossref","first-page":"32350","DOI":"10.1038\/srep32350","article-title":"SOX9-regulated cell plasticity in colorectal metastasis is attenuated by rapamycin","volume":"6","author":"Carrasco-Garcia","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2023.154602_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1756-9966-31-18","article-title":"Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival","volume":"31","author":"Zhou","year":"2012","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.prp.2023.154602_bib17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12032-014-0358-0","article-title":"Clinical implication of Sox9 and activated Akt expression in pancreatic ductal adenocarcinoma","volume":"32","author":"Xia","year":"2015","journal-title":"Med. Oncol."},{"key":"10.1016\/j.prp.2023.154602_bib18","first-page":"137","article-title":"Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence-free survival in patients with prostate cancer","volume":"7","author":"Qin","year":"2014","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.prp.2023.154602_bib19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fonc.2014.00118","article-title":"Prognostic significance of beta-catenin, E-Cadherin, and SOX9 in colorectal cancer: results from a large population-representative series","volume":"4","author":"Bruun","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2023.154602_bib20","doi-asserted-by":"crossref","first-page":"19693","DOI":"10.18632\/oncotarget.7564","article-title":"Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors","volume":"7","author":"Lapierre","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2023.154602_bib21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10120-013-0277-3","article-title":"Aberrant expression of SOX9 is associated with gastrokine 1 inactivation in gastric cancers","volume":"17","author":"Choi","year":"2014","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.prp.2023.154602_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/hep.28509","article-title":"Sox9 regulates self-renewal and tumorigenicity by promoting symmetrical cell division of cancer stem cells in hepatocellular carcinoma","volume":"64","author":"Liu","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.prp.2023.154602_bib23","first-page":"736","article-title":"Association of SOX9 expression and prognosis in patients with gastric cancer","volume":"15","author":"Shao","year":"2012","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"10.1016\/j.prp.2023.154602_bib24","first-page":"848","article-title":"SOX9 expression correlates with microvascular density, progress and prognosis in gastric cancer patients","volume":"41","author":"Wang","year":"2012","journal-title":"Zhonghua Bing. Li Xue Za Zhi"},{"key":"10.1016\/j.prp.2023.154602_bib25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1746-1596-8-183","article-title":"Upregulation of SOX9 in osteosarcoma and its association with tumor progression and patients' prognosis","volume":"8","author":"Zhu","year":"2013","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.prp.2023.154602_bib26","first-page":"4795","article-title":"Sox9 regulates hyperexpression of Wnt1 and Fzd1 in human osteosarcoma tissues and cells","volume":"7","author":"Liu","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.prp.2023.154602_bib27","first-page":"10130","article-title":"Decreased expression of SOX9 indicates a better prognosis and inhibits the growth of glioma cells by inducing cell cycle arrest","volume":"8","author":"Gao","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.prp.2023.154602_bib28","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1158\/1078-0432.CCR-17-0177","article-title":"Expression and therapeutic potential of SOX9 in chordoma","volume":"23","author":"Chen","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2023.154602_bib29","first-page":"4898","article-title":"SOX9 regulated proliferation and apoptosis of human lung carcinoma cells by the Wnt\/beta-catenin signaling pathway","volume":"22","author":"Guo","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.prp.2023.154602_bib30","doi-asserted-by":"crossref","first-page":"6197","DOI":"10.1038\/s41598-020-63279-y","article-title":"MicroRNA-520f-3p inhibits proliferation of gastric cancer cells via targeting SOX9 and thereby inactivating Wnt signaling","volume":"10","author":"Chen","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2023.154602_bib31","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1172\/JCI78815","article-title":"SOX9 drives WNT pathway activation in prostate cancer","volume":"126","author":"Ma","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.prp.2023.154602_bib32","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ijc.29425","article-title":"Sprouty 2 protein, but not Sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancer","volume":"137","author":"Masoumi-Moghaddam","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2023.154602_bib33","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.biopha.2016.07.038","article-title":"Inhibition of microRNA-383 has tumor suppressive effect in human epithelial ovarian cancer through the action on caspase-2 gene","volume":"83","author":"Liu","year":"2016","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.prp.2023.154602_bib34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1186\/s12935-021-02295-y","article-title":"Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response","volume":"21","author":"Zhang","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.prp.2023.154602_bib35","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0046-8177(87)80412-4","article-title":"ras p21 expression in the progression of breast cancer","volume":"18","author":"Fromowitz","year":"1987","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2023.154602_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101658","article-title":"Wnt signaling in ovarian cancer stemness, EMT, and therapy resistance","volume":"8","author":"Teeuwssen","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.prp.2023.154602_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188517","article-title":"SOX9: an emerging driving factor from cancer progression to drug resistance","volume":"1875","author":"Panda","year":"2021","journal-title":"Biochim Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.prp.2023.154602_bib38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.gendis.2014.09.004","article-title":"The versatile functions of Sox9 in development, stem cells, and human diseases","volume":"1","author":"Jo","year":"2014","journal-title":"Genes Dis."},{"key":"10.1016\/j.prp.2023.154602_bib39","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ygyno.2019.03.099","article-title":"SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma","volume":"153","author":"Sherman-Samis","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.prp.2023.154602_bib40","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1002\/jcb.26865","article-title":"MiR-34c\/SOX9 axis regulates the chemoresistance of ovarian cancer cell to cisplatin-based chemotherapy","volume":"120","author":"Xiao","year":"2019","journal-title":"J. Cell Biochem"},{"key":"10.1016\/j.prp.2023.154602_bib41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.gene.2014.03.037","article-title":"Sox9 and Hif-2alpha regulate TUBB3 gene expression and affect ovarian cancer aggressiveness","volume":"542","author":"Raspaglio","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.prp.2023.154602_bib42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1476-4598-13-129","article-title":"MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress","volume":"13","author":"Felder","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2023.154602_bib43","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/bjc.2011.34","article-title":"Downregulation of cell surface CA125\/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells","volume":"104","author":"Comamala","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2023.154602_bib44","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ijbiomac.2021.04.185","article-title":"Interplay between SOX9 transcription factor and microRNAs in cancer","volume":"183","author":"Ashrafizadeh","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154602_bib45","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1080\/15384101.2020.1807094","article-title":"MALAT1 overexpression attenuates AS by inhibiting ox-LDL-stimulated dendritic cell maturation via miR-155-5p\/NFIA axis","volume":"19","author":"Chen","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.prp.2023.154602_bib46","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/cam4.1434","article-title":"Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma","volume":"7","author":"Yang","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.prp.2023.154602_bib47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/neuonc\/not167","article-title":"A novel tumor-promoting role for nuclear factor IA in glioblastomas is mediated through negative regulation of p53, p21, and PAI1","volume":"16","author":"Lee","year":"2014","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.prp.2023.154602_bib48","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.urolonc.2013.06.014","article-title":"Differentiating progressive from nonprogressive T1 bladder cancer by gene expression profiling: applying RNA-sequencing analysis on archived specimens","volume":"32","author":"Sharron Lin","year":"2014","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.prp.2023.154602_bib49","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1007\/s12035-021-02345-6","article-title":"MiR-124 and small molecules synergistically regulate the generation of neuronal cells from rat cortical reactive astrocytes","volume":"58","author":"Zheng","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.prp.2023.154602_bib50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuron.2012.01.024","article-title":"Sox9 and NFIA coordinate a transcriptional regulatory cascade during the initiation of gliogenesis","volume":"74","author":"Kang","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.prp.2023.154602_bib51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"Emt: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.prp.2023.154602_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.28160","article-title":"The basics of epithelial-mesenchymal transition (EMT): a study from a structure dynamics and functional perspective","author":"Das","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.prp.2023.154602_bib53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","article-title":"The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis","volume":"15","author":"Huang","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.prp.2023.154602_bib54","first-page":"509","article-title":"Molecular mechanisms of epithelial to mesenchymal transition in tumor metastasis","volume":"66","author":"Nieszporek","year":"2019","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.prp.2023.154602_bib55","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1200\/JCO.2016.66.9010","article-title":"Randomized Phase III trial of irinotecan plus cisplatin compared with paclitaxel plus carboplatin as first-line chemotherapy for ovarian clear cell carcinoma: JGOG3017\/GCIG trial","volume":"34","author":"Sugiyama","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2023.154602_bib56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12943-016-0497-3","article-title":"Does VEGF facilitate local tumor growth and spread into the abdominal cavity by suppressing endothelial cell adhesion, thus increasing vascular peritoneal permeability followed by ascites production in ovarian cancer","volume":"15","author":"Bekes","year":"2016","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2023.154602_bib57","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1158\/1078-0432.CCR-20-0054","article-title":"CA-125 ELIMination Rate Constant K (KELIM) is a marker of chemosensitivity in patients with ovarian cancer: results from the phase II CHIVA Trial","volume":"26","author":"You","year":"2020","journal-title":"Clin. Cancer Res"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823003023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823003023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:06:11Z","timestamp":1774411571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823003023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":57,"alternative-id":["S0344033823003023"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154602","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SOX9\/NFIA promotes human ovarian cancer metastasis through the Wnt\/\u03b2-catenin signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"154602"}}